PRECEF Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Precef, and when can generic versions of Precef launch?
Precef is a drug marketed by Apothecon and Bristol and is included in two NDAs.
The generic ingredient in PRECEF is ceforanide. There is one drug master file entry for this compound. Additional details are available on the ceforanide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRECEF?
- What are the global sales for PRECEF?
- What is Average Wholesale Price for PRECEF?
Summary for PRECEF
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 54 |
| DailyMed Link: | PRECEF at DailyMed |
US Patents and Regulatory Information for PRECEF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | PRECEF | ceforanide | INJECTABLE;INJECTION | 062579-002 | Nov 26, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bristol | PRECEF | ceforanide | INJECTABLE;INJECTION | 050554-003 | May 24, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | PRECEF | ceforanide | INJECTABLE;INJECTION | 062579-005 | Nov 26, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
